Will 2-18 year olds also get Covaccine?

baby girl for vaccination

Will 2-18 year olds also get Covaccine? Approval for the use of indigenous vaccine sought in America. read more

  • The world finally accepted the iron of India’s indigenous vaccine, Covaccine. After getting approval from the World Health Organization, now its acceptance has increased all over the world.
  • If all goes well, Bharat Biotech’s Covaccine could be given to children in the age group of two to 18 years. Ocugen Inc.
  • partner of Bharat Biotech in the US and Canada, on Friday said it has applied to the US Food and Drug Administration (FDA) for the use of an anti-Covid-19 vaccine for children.

OcuGen has told the regulator that its application is based on the results of a phase II-III ‘clinical trial’ conducted by Bharat Biotech on 526 children and adolescents in the age group of two to 18 years in India. The results of a Phase III study conducted on about 25,800 adults in India are also cited to determine the vaccine’s efficacy. With regard to pediatric use, said Shankar Musunuri, CEO, co-founder and chairman of the board, Okugain. Applying for emergency use in the US is a step towards making vaccines available and helping combat the COVID-19 pandemic. Step is step is important step. He said some studies have suggested that people want more choices in the selection of vaccines for themselves, and especially for their children. The availability of new types of vaccines will enable people to consult doctors and make better decisions for their children. Recently the World Health Organization (WHO) has approved the emergency use of Covaccine. Let us inform that the recommendation of the World Health Organization (WHO) to approve the vaccine has brought a sigh of relief for thousands of Indians who are planning to travel abroad in connection with studies or business. In fact, vaccines included in the WHO emergency list are considered to be highly effective and safe globally. Listing the vaccine for emergency use will prompt all the countries of the world to approve the inclusion of this vaccine developed in India in the vaccine passport. Due to this, passengers getting the vaccine will not need to be quarantined after reaching the country concerned. They will also be exempted from presenting the negative report of the corona investigation. Some important stages of Covaccine

covid-19
  1. 19 April 2021 : Bharat Biotech submits EOI (Expression of Interest) for inclusion of Covaccine in WHO’s emergency use list
  2. 26 October 2021: WHO’s technical advisory group reviews vaccine clinical trial data, calls for additional information
  3. 03 November 2021 : Technical Advisory Group recommends listing of Covaccine for emergency use after analysis of documents

Let us inform that the recommendation of the World Health Organization (WHO) to approve the vaccine has brought a sigh of relief for thousands of Indians who are planning to travel abroad in connection with studies or business. In fact, vaccines included in the WHO emergency list are considered to be highly effective and safe globally. Listing the vaccine for emergency use will prompt all the countries of the world to approve the inclusion of this vaccine developed in India in the vaccine passport. Due to this, passengers getting the vaccine will not need to be quarantined after reaching the country concerned. They will also be exempted from presenting the negative report of the corona investigation.

Some important stages of Covaccine

  • 19 April 2021 : Bharat Biotech submits EOI (Expression of Interest) for inclusion of Covaccine in WHO’s emergency use list
  • 26 October 2021: WHO’s technical advisory group reviews vaccine clinical trial data, calls for additional information
  • 03 November 2021 : Technical Advisory Group recommends listing of Covaccine for emergency use after analysis of documents

These countries accepted – Australia, Estonia, Kyrgyzstan, Palestine, Mauritius, Mongolia, Oman

Be the first to comment

Leave a Reply

Your email address will not be published.


*